Kazia Therapeutics Limited - ADR
KZIA
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.7M
Close$
$2.57
76.6% downside
Current Fair Value
76.6% downsideOvervalued by 76.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.70 Million |
|---|---|
| Enterprise Value | $-48,591,435.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-18.9 |
| Beta | 2.23 |
| Outstanding Shares | 3,120,426 |
Return
| Return on Equity | -97.92% |
|---|---|
| Return on Assets | -63.98% |
| Return on Invested Capital | -90.83% |
Valuation & Multiples
| P/E Ratio | -2.49 |
|---|---|
| PEG | -1.84 |
| Price to Sales | - |
| Price to Book Ratio | 0.78 |
| Enterprise Value to Revenue | -19.34 |
| Enterprise Value to EBIT | 1.15 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 16, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 4, 2026
EPS Estimate
$-0.83
Average shareholder expectationRevenue Estimate
$208,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 56.21%▲ 56.21% |
|---|---|
| Total Invested | $13.05M |
| Investors Holding | 23▲ 23.00% |
ESG Score
No data